Diseases, Conditions, Syndromes

mRNA vaccine yields full protection against malaria in mice

Scientists from the Walter Reed Army Institute of Research and Naval Medical Research Center partnered with researchers at the University of Pennsylvania and Acuitas Therapeutics to develop a novel vaccine based on mRNA technology ...

Diseases, Conditions, Syndromes

Will the COVID-19 vaccine work as well in patients with obesity?

When researchers began to develop what they hoped would be an effective COVID-19 vaccine, they already knew that H1N1 influenza—a novel virus, like COVID-19 – more severely affected patients with overweight or obesity. ...

Diseases, Conditions, Syndromes

Testing tuberculosis vaccine combinations for COVID-19

Researchers at the University of Sydney and Centenary Institute are repurposing an existing tuberculosis vaccine to see if it can be used in a new way against COVID-19 to develop a novel vaccine.

Diseases, Conditions, Syndromes

Promising pre-clinical results for COVID-19 vaccine

A COVID-19 vaccine candidate developed by the University of Saskatchewan's (USask) Vaccine and Infectious Disease Organization-International Vaccine Centre (VIDO-InterVac) has cleared another major milestone in moving towards ...

Diseases, Conditions, Syndromes

Breakthrough in Zika virus vaccine

Researchers from the University of Adelaide have made significant advances in developing a novel vaccine against Zika virus, which could potentially lead to global elimination of the disease.

Diseases, Conditions, Syndromes

UN: 'Substantial risks' remain in Congo's Ebola outbreak

The World Health Organization says "substantial risks" remain in the ongoing Ebola outbreak in northeastern Congo, noting that while control measures appear to be working, health officials are still unable to track exactly ...

page 1 from 3